Effects of Early Community Services on Child and Family Development

NCT04019977 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 277

Last updated 2025-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of the current study is to evaluate the effects on early child development of early community services, including a brief nurse home visiting program. Investigators hypothesize that nurse home visiting program participants will be significantly different than non- nurse home visiting program participants on the following child and family outcomes: (a) (reduced) infant emergency room use and overnight hospital stays; (b) (increased) family use of community resources and (higher quality) child care; (c) (increased) maternal wellbeing; and (d) (increased) quality of the home environment, including home safety and supportive parenting by both parents. The study will also explore long-term differences between the nurse home visiting program recipients and non-recipients in (a) rates of official investigations for child maltreatment and (b) two indicators of early educational achievement: kindergarten readiness scores and rates of kindergarten attendance.

Conditions

  • Child Development

Interventions

OTHER

Nurse Home Visiting Program

Brief nurse home visiting program

Sponsors & Collaborators

  • LifeBridge Health

    collaborator OTHER
  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Lisa J Berlin, PhD · University of Maryland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-18
Primary Completion
2020-09-29
Completion
2021-07-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04019977 on ClinicalTrials.gov